Vivos Inc (RDGL)

[WhAtEvA1]

First off, what he stated isn't his opinion. That Isopet destroy tumors without damage to surrounding tissue is fact based that the FDA reviewed before approving Isopet for marketing. That underlying data is why the FDA wants a trial for humans and the chances of success is high. So, instead of putting forth a redherring that Isopet doesn't make money (as if ability to generate money is the reason it was approved), perhaps you should consider the fact Vivos is a startup with little to no financial muscle for extensive marketing infrastructure and clinics setup? The whole game, including "money making" cum increased publicity profile most definitely will change for Vivos and Isopet the moment clinical human trial data for Radiogel further validates what is already proven in animal tumor treatments. IMO, post FDA approval for Radiogel marketing, partnering interest will be high for Vivos and its products. The successful trial for the first indication will be game changing to say the least. So, be patient and watch events unfold. There is something the FDA is seeing and sensing that prompted the current review pathway for Radiogel. We will see in due time. All IMHO.